Abeona Therapeutics annual gross margin
2010
2011
2012
2013
2014
2022
2023
2025
Abeona Therapeutics Gross Margin Growth & History (ABEO)
Abeona Therapeutics's gross margin was 73.68% for fiscal 2025.
View full Abeona Therapeutics company overviewAbeona Therapeutics annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 73.68% | — |
| 2023 | 2023-12-31 | 54.14% | −14.03 pp |
| 2022 | 2022-12-31 | 68.18% | — |
| 2014 | 2014-12-31 | 100.00% | +6.12 pp |
| 2013 | 2013-12-31 | 93.88% | −0.06 pp |
| 2012 | 2012-12-31 | 93.94% | +1.99 pp |
| 2011 | 2011-12-31 | 91.95% | +21.06 pp |
| 2010 | 2010-12-31 | 70.89% | — |
Abeona Therapeutics quarterly gross margin
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q2.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 63.30% | −11.70 pp |
| Q1 2026 | 2026-03-31 | 69.08% | — |
| Q4 2025 | 2025-12-31 | 47.66% | — |
| Q2 2025 | 2025-06-30 | 75.00% | — |
| Q4 2014 | 2014-12-31 | 100.00% | 0.00 pp |
| Q3 2014 | 2014-09-30 | 100.00% | +3.70 pp |
| Q2 2014 | 2014-06-30 | 100.00% | +11.35 pp |
| Q1 2014 | 2014-03-31 | 100.00% | +5.31 pp |
| Q4 2013 | 2013-12-31 | 100.00% | +6.56 pp |
| Q3 2013 | 2013-09-30 | 96.30% | +5.37 pp |
| Q2 2013 | 2013-06-30 | 88.65% | −2.22 pp |
| Q1 2013 | 2013-03-31 | 94.69% | −2.10 pp |
| Q4 2012 | 2012-12-31 | 93.44% | −61.09 pp |
| Q3 2012 | 2012-09-30 | 90.93% | −3.21 pp |
| Q2 2012 | 2012-06-30 | 90.87% | +167.03 pp |
| Q1 2012 | 2012-03-31 | 96.79% | +58.12 pp |
| Q4 2011 | 2011-12-31 | 154.53% | — |
| Q3 2011 | 2011-09-30 | 94.14% | −5.86 pp |
| Q2 2011 | 2011-06-30 | −76.16% | −176.16 pp |
| Q1 2011 | 2011-03-31 | 38.67% | — |
| Q3 2010 | 2010-09-30 | 100.00% | — |
| Q2 2010 | 2010-06-30 | 100.00% | — |
Abeona Therapeutics gross margin trends
Between the periods ended 2010-12-31 and 2025-12-31, Abeona Therapeutics's gross margin increased from 70.89% to 73.68%, a change of +2.78 percentage points. The latest reported quarter, Q2 2026, shows 63.30%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Abeona Therapeutics source filings ↗